Stock NUS NU SKIN ENTERPRISES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Nu Skin Enterprises, Inc.

Equities

NUS

US67018T1051

Market Closed - Nyse
Other stock markets
 16:00:02 2024-04-26 EDT 		5-day change 1st Jan Change
12.31 USD +0.57% Intraday chart for Nu Skin Enterprises, Inc. -5.38% -36.61%
03-18 Nu Skin Enterprises, Inc. Announces Retirement of Andrew Lipman as Board of Directors CI
02-15 Sector Update: Consumer Stocks Advance Premarket Thursday MT

Strengths

  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • With a P/E ratio at 12.37 for the current year and 8.29 for next year, earnings multiples are highly attractive compared with competitors.
  • The stock, which is currently worth 2024 to 0.45 times its sales, is clearly overvalued in comparison with peers.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

  • According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company does not generate enough profits, which is an alarming weak point.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Personal Products

1st Jan change Capi. Investor Rating ESG Refinitiv
NU SKIN ENTERPRISES, INC. Stock Nu Skin Enterprises, Inc.
-36.61% 611M
C+
UNILEVER PLC Stock Unilever PLC
+8.76% 129B
B-
COLGATE-PALMOLIVE COMPANY Stock Colgate-Palmolive Company
+14.18% 74.67B
A+
HINDUSTAN UNILEVER LIMITED Stock Hindustan Unilever Limited
-16.59% 62.59B
A-
ESTEE LAUDER Stock Estee Lauder
+0.82% 52.86B
B+
KENVUE INC. Stock Kenvue Inc.
-12.40% 36.11B -
BEIERSDORF Stock Beiersdorf
+3.54% 33.57B
B-
ESSITY AB Stock Essity AB
+7.92% 17.29B
A-
GODREJ CONSUMER PRODUCTS LIMITED Stock Godrej Consumer Products Limited
+6.30% 14.75B
B
DABUR INDIA LIMITED Stock Dabur India Limited
-8.65% 10.82B
C+
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. NUS Stock
  4. Ratings Nu Skin Enterprises, Inc.